These results are accordant to the reports showing the oncogenic of TACC3 in multiple myeloma [9, 19], lung [20], bladder [21, 22], cervix uteri [18], breast [23] and ovarian cancer [35, 36]. This evidence concerns the gene TACC3 and ovarian carcinoma.